These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 27776495)

  • 1. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa.
    Black S; Zulliger R; Marcus R; Mark D; Myer L; Bekker LG
    AIDS Care; 2014; 26(6):736-41. PubMed ID: 24200029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
    Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
    SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deterrents to Immediate Antiretroviral Therapy Initiation by Pregnant Women Living with HIV in Hhohho Region, Swaziland.
    Mamba HT; Hlongwana KW
    Afr J Reprod Health; 2018 Dec; 22(4):72-80. PubMed ID: 30632724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland.
    Parker LA; Jobanputra K; Okello V; Nhlangamandla M; Mazibuko S; Kourline T; Kerschberger B; Pavlopoulos E; Teck R
    J Acquir Immune Defic Syndr; 2015 May; 69(1):e24-30. PubMed ID: 25622060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lay health worker experiences administering a multi-level combination intervention to improve PMTCT retention.
    DiCarlo A; Fayorsey R; Syengo M; Chege D; Sirengo M; Reidy W; Otieno J; Omoto J; Hawken MP; Abrams EJ
    BMC Health Serv Res; 2018 Jan; 18(1):17. PubMed ID: 29321026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Option B+ Program for the Prevention of Vertical Transmission of HIV: A Case Study in Johannesburg, South Africa.
    Bisnauth MA; Coovadia A; Mbuagbaw L; Wilson MG; Birch S
    Front Public Health; 2020; 8():533534. PubMed ID: 33194942
    [No Abstract]   [Full Text] [Related]  

  • 14. Acceptability of community-based mentor mothers to support HIV-positive pregnant women on antiretroviral treatment in western Kenya: a qualitative study.
    Wanga I; Helova A; Abuogi LL; Bukusi EA; Nalwa W; Akama E; Odeny TA; Turan JM; Onono M
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):288. PubMed ID: 31409297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland.
    Etoori D; Kerschberger B; Staderini N; Ndlangamandla M; Nhlabatsi B; Jobanputra K; Mthethwa-Hleza S; Parker LA; Sibanda S; Mabhena E; Pasipamire M; Kabore SM; Rusch B; Jamet C; Ciglenecki I; Teck R
    BMC Public Health; 2018 Mar; 18(1):374. PubMed ID: 29558896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
    Larsen A; Magasana V; Dinh TH; Ngandu N; Lombard C; Cheyip M; Ayalew K; Chirinda W; Kindra G; Jackson D; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):789. PubMed ID: 31526366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries.
    Kieffer MP; Mattingly M; Giphart A; van de Ven R; Chouraya C; Walakira M; Boon A; Mikusova S; Simonds RJ;
    J Acquir Immune Defic Syndr; 2014 Dec; 67 Suppl 4(Suppl 4):S188-94. PubMed ID: 25436817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.